A comparative study of mirabegron versus doxazosin in improving ureteral stent-related dysfunction - Top-Institutions - MDSpire

A comparative study of mirabegron versus doxazosin in improving ureteral stent-related dysfunction

  • By

  • Bo Tao

  • Enyan Jiang

  • Yuan Zhao

  • Zhangxiao Xu

  • Juan Yang

  • Lijun Wang

  • May 13, 2025

  • 0 min

Share

Top Institutions in Urology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Urology
    • Clinical Pharmacology

  • #2

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Urology
    • Neurourology

  • #3

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Urology
    • Translational Medicine

  • #4

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Urology
    • Clinical Trials

  • #5

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Urology
    • Pharmacology

Original Source(s)

A comparative study of mirabegron versus doxazosin in improving ureteral stent-related dysfunction

  • by Bo Tao, Enyan Jiang, Yuan Zhao, Zhangxiao Xu, Juan Yang, Lijun Wang

  • May 13, 2025

Related Content

Transurethral resection of the prostate across continents: a meta-analysis evaluating quality of gold standard in the twenty-first century

Multivariable regression analysis of perioperative parameters for a novel pulsed solid-state Thulium: YAG laser with high peak power versus Holmium: YAG laser in prostate enucleation

Analyzing retraction trends in urology: a comprehensive study over the last decade